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Abstract
Macrophages are a heterogeneous cell population playing a pivotal role in tissue homeosta-
sis and inflammation, and their phenotype strongly depends on the micromilieu. Despite its
increasing importance as a translational animal model for human diseases, there is a con-
siderable gap of knowledge with respect to macrophage polarization in dogs. The present
study comprehensively investigated the morphologic, phenotypic, and transcriptomic char-
acteristics of unstimulated (M0), M1- (GM-CSF, LPS, IFNγ-stimulated) and M2- (M-CSF, IL-
4-stimulated)-polarized canine blood-derived macrophages in vitro. Scanning electron
microscopy revealed distinct morphologies of polarized macrophages with formation of mul-
tinucleated cells in M2-macrophages, while immunofluorescence employing literature-
based prototype-antibodies against CD16, CD32, iNOS, MHC class II (M1-markers),
CD163, CD206, and arginase-1 (M2-markers) demonstrated that only CD206 was able to
discriminate M2-macrophages from both other phenotypes, highlighting this molecule as a
promising marker for canine M2-macrophages. Global microarray analysis revealed pro-
found changes in the transcriptome of polarized canine macrophages. Functional analysis
pointed out that M1-polarization was associated with biological processes such as “respira-
tory burst”, whereas M2-polarization was associated with processes such as “mitosis”. Liter-
ature-based marker gene selection revealed only minor overlaps in the gene sets of the dog
compared to prototype markers of murine and human macrophages. Biomarker selection
using supervised clustering suggested latexin (LXN) and membrane-spanning 4-domains,
subfamily A, member 2 (MS4A2) to be the most powerful predicting biomarkers for canine
M1- and M2-macrophages, respectively. Immunofluorescence for both markers demon-
strated expression of both proteins by macrophages in vitro but failed to reveal differences
between canine M1 and M2-macrophages. The present study provides a solid basis for
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Introduction
Circulating peripheral blood mononuclear cells (PBMCs) play an important role during both
the steady state and inflammation. Monocytes, which originate from hematopoietic stem cells,
are capable of migrating from the blood into distinct tissues and differentiate into macro-
phages in order to replenish specific tissue-specific macrophage populations [1]. Functional
diversity and plasticity are hallmarks of macrophages [2, 3]. Together they represent a hetero-
geneous cell population of the mononuclear phagocyte system playing a pivotal role in tissue
homeostasis, inflammation, host defense, and tissue repair [4, 5]. Depending on the micromi-
lieu, two extremes of macrophage phenotypes have been described following external or
endogenous stimulation: “classically” activated M1-macrophages and “alternatively” activated
M2-macrophages [6, 7]. Classically activated M1-macrophages develop after exposure to pro-
inflammatory stimuli such as interferon γ (IFNγ), lipopolysaccharide (LPS), or tumor necrosis
factor (TNF). Subsequent to such stimulation, M1-macrophages release pro-inflammatory
cytokines, reactive oxygen species (ROS), and nitric oxide (NO) [8]. Hence, on the functional
level, M1-macrophages are characterized by an increased microbicidal, tumoricidal, and anti-
gen presenting capacity [2, 4, 9]. In contrast, M2-macrophages become activated in the pres-
ence of interleukin (IL)-4, IL-10, IL-13, glucocorticoids, and transforming growth factor β
(TGFβ) leading to enhanced secretion of anti-inflammatory cytokines. Accordingly, M2-mac-
rophages are functionally associated with hypersensitivity, parasite clearance, inflammatory
dampening, tissue remodeling, angiogenesis, immunoregulation, and tumor promotion [2, 9,
10]. However, it should be taken into consideration that the M1-/M2–paradigm is a simplified
classification, representing only two extremes of phenotypes which do not fully mirror the
complexity of the dynamic biological processes behind cell polarization [7]. Hence, gene
expression profiling has been applied as a sophisticated technique to detect the underlying
molecular mechanisms following macrophage activation in murine and human cells [11–14].
In fact, macrophage activation by any agonist involves a massive change in gene expression
during the transition from one steady state to another [5]. Notably, current comparative stud-
ies strongly support the observation of marked interspecies differences and variability between
mice and humans indicating that about 50% of polarization specific markers are selectively
expressed in only one of both species [13, 14].
Currently, spontaneous diseases in dogs play an established and increasing role as suitable
animal models for human disorders including for instance demyelinating central nervous sys-
tem (CNS) diseases, measles, cancer, and spinal cord injury (SCI) [15–21]. Conclusively, dogs
represent a promising so called large animal model in the development of novel therapeutic
approaches for naturally occurring diseases. However, despite the essential role of dogs as a
translational animal model, there is a considerable lack of knowledge of the role of macro-
phage polarization in this species, and morphologic, phenotypic, and transcriptomic proper-
ties of polarized canine macrophages are enigmatic so far. However, a detailed knowledge of
these basic principles doubtlessly represents a prerequisite for envisaged pharmacotherapeutic
and cell transplantation studies.
Therefore, this in vitro study aimed to (i) characterize morphological differences of polar-
ized canine macrophages, (ii) to test the capability of established murine and human prototyp-
ical markers to differentiate canine M1- and M2-macrophages using immunofluorescence,
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and (iii) to unravel differences in the transcriptome of canine polarized macrophages using
microarray technique in order to establish unique gene signatures, which differentiate these
polarization states.
The presented results provide a highly needed basis for future research upon canine sponta-
neous diseases such as SCI and distemper leukoencephalitis with a special emphasis upon the
so far enigmatic role of macrophage polarization in these diseases.
Materials and methods
Blood cell isolation
Blood samples were collected from a total number of 12 healthy Beagle dogs, which were kept
in regulatory approved animal housing facilities of the Departments of Small Animal Medicine
and Surgery and the Institute for Parasitology, University of Veterinary Medicine, Hannover,
Germany. Blood collection was done by professional veterinarians from non-anesthetized
dogs following the regulations of the German Animal Welfare Law and with permission pro-
vided by the Niedersa¨chsisches Landesamt fu¨r Verbraucherschutz und Lebensmittelsicherheit,
Oldenburg, Germany (permission number: AZ33.9-42502-05-13A303). Following a clinical
examination of each animal, which included auscultation of the lung and heart, and rectal
measurement of the body temperature, the puncture spot was disinfected. A volume of 20 ml
blood was collected from the cephalic vein of each dog. Following blood collection, local man-
ual pressure was used to avoid bleeding. No animals were euthanized for the present study.
Peripheral blood mononuclear cells (PBMCs) were isolated via density gradient centrifuga-
tion using a routine protocol as described previously [22]. Briefly, blood samples were diluted
1:3 in phosphate buffered saline (PBS) containing 1% penicillin/streptomycin (Biochrom
GmbH, Berlin, Germany) and added onto a gradient with equal volumes of histopaque 1.077
g/ml and 1.119 g/ml (Sigma Aldrich, Taufkirchen, Germany). After 30 minutes of centrifuga-
tion, cells were harvested using a Pasteur pipette, washed with PBS and 1% penicillin/strepto-
mycin followed by depletion of erythrocyte contamination by hypotone lysis with distilled
water. Subsequently, cells were resuspended in Roswell Park Memorial Institute (RPMI)-
medium 1640 (Biochrom GmbH, Berlin, Germany) containing 10% fetal calf serum (PAA,
Co¨lbe, Germany) and 1% penicillin/streptomycin and seeded onto 96½-well plates (Thermo-
Scientific, Waltham, MA, USA) at a density of 0.3 x 10^6 cells/well. After 24 hours of cultiva-
tion under standard conditions (5% CO2, 37˚C), medium was completely removed and cells
were washed twice with PBS and 1% penicillin/streptomycin. Cells attached to the base of
wells with strong plastic adherence were referred to as monocytes [23–26].
Cell culture and polarization
To culture canine macrophages in vitro from blood-derived monocytes, a protocol according
to Durafourt et al. (2012) [27] was used with slight modifications. Briefly, canine monocytes
were cultured over 7 days towards M1-/M2-macrophages by stimulation with hematopoietic
growth factors over 5 days followed by activation over 2 days with distinct cytokines, pur-
chased from companies that guarantee an endotoxin level below 0.1 EU/μg of protein. In par-
ticular, to obtain M1-macrophages, monocytes were treated with 5 ng/ml canine recombinant
granulocyte macrophage colony-stimulating factor (GM-CSF; R&D Systems, Minneapolis,
MN, USA), 100 ng/ml LPS (Sigma Aldrich, Taufkirchen, Germany), and 20 ng/ml recombi-
nant canine IFNγ (Kingfisher Biotech Inc., Saint Paul, Minnesota, USA). M2-macrophages
were developed by treatment with 25 ng/ml human macrophage colony-stimulating factor
(M-CSF, PeproTech Inc., Rocky Hill, NJ, USA) and 20 ng/ml canine recombinant IL-4 (R&D
Systems, Minneapolis, MN, USA). Serving as a control, unstimulated monocytes were cultured
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under the same conditions with medium change every second day (M0-macrophages). After 7
days of cultivation, morphology, phenotype, and transcriptomic changes of M0-, M1-, and
M2-macrophages were assessed. Pictures were taken with an inverted fluorescence microscope
(Olympus IX-70, Olympus, Optical Co GmbH, Hamburg, Germany).
The overall number of cells for each polarization was counted on at least 4 microscopic pic-
tures (200x magnification) of three individual dogs on day 7 in culture and the mean numbers
of cells per 200x field were compared using one-factorial ANOVA and post-hoc t tests apply-
ing SPSS version 21 for windows (IBM Inc., Chicago, USA).
For quantification of cellular morphology, microphotographs were taken at 200x magnifi-
cation and the number of cells with a distinct morphologic appearance out of at least 100
randomly selected cells was counted for each polarization (M0, M1, M2). Here, 4 distinct mor-
phologic types were defined. In particular, cells with a cellular diameter 10 μm and absent
cytoplasmic projections on the cellular surface were defined as small/roundish cells (morphol-
ogy 1); cells with a cellular diameter 10 μm and numerous cytoplasmic processes were
defined as amoeboid (morphology 2); cells obtaining an elongated bipolar morphology were
classified as spindeloid (morphology 3); and cells possessing a large, round, and flattened mor-
phology with a cellular diameter 30 μm and> 1 nuclei were classified as multinucleated
giant cells (MNGs; morphology 4).
The percentage of each of the four different morphologies was calculated in M0-, M1-, and
M2-macrophages from 3 animals. A mixed ANOVA with post-hoc alpha adjustment (Tukey-
Kramer) and significance level at p0.05 was performed using the statistical software pro-
gramme SPSS version 21 for windows (IBM Inc., Chicago, USA) in order to compare the per-
centages of each of the morphologies between M0-, M1-, and M2-macrophages. Graphical
compilation was done with GraphPad Prism 5.0 (GraphPad Software Inc., La Jolla, USA).
Scanning electron microscopy
M0-, M1-, and M2-macrophages were prepared for representative ultrastructural characteriza-
tion using scanning electron microscopy as described previously [28]. Briefly, cells were fixed
in 2.5% glutaraldehyde/cacodylate buffer, post-fixed in 1% osmium tetroxide, and dehydrated
in a graded series of alcohol. Subsequently, cells were dried under a Critical Point Dryer
(E3000, Polaron, London, UK), and sputter-coated with gold, and examined under a digital
scanning electron microscope (DSM 940, Zeiss, Oberkochen, Germany). At least 50 cells were
photographed for each morphology and evaluated with regard to ultrastructural morphology.
Immunocytochemistry
Immunolabelling of canine M0-, M1-, and M2-macrophages from 5 individuals was per-
formed using a routine protocol described previously [29, 30]. A panel of different literature-
based prototype marker antibodies, reported to distinguish between M1- and M2-macro-
phages was applied (Table 1; [4, 31]). Briefly, cells were fixed with paraformaldehyde (PFA,
4%) for 20 minutes at room temperature (RT) and permeabilized with Triton X (0.25%)
diluted in PBS (PBST). Non-specific binding was blocked by treatment of cells with bovine
serum albumin (BSA, 3%; Sigma Aldrich, Taufkirchen, Germany) and normal goat serum
(5%) diluted in PBST for 15 minutes at RT, except for cells intended to be stained with anti-
bodies directed against Fc-receptors, i.e. CD16 and CD32. Subsequently, primary antibodies
(Table 1) were added and incubated for 2 hours at RT. All unconjugated primary antibodies
were labeled with secondary goat-anti-mouse antibodies coupled to cyanine 3 (Cy3), goat-
anti-rat antibodies coupled to Cy2, and goat-anti-rabbit antibodies coupled to Cy3 (all
received from Jackson ImmunoResearch Laboratories, Dianova, Hamburg, Germany; dilution
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1:200 in PBS), respectively, and incubated for 2 hours at RT. Following appropriate washing
steps with PBS and distilled water, nuclei were counterstained with bisbenzimide (H33258,
0.01% in distilled water) for 5 minutes at RT. Species-specific immunoglobulins from mouse,
rat, goat, and rabbit diluted according to the immunoglobulin concentration of the primary
antibodies served as appropriate negative controls. M0-, M1-, and M2-macrophages were
investigated using an inverted fluorescence microscope (Olympus IX-70, Olympus, Optical Co
GmbH, Hamburg, Germany). For quantification of immunopositivity, microphotographs
were taken at 200x magnification and at least 100 randomly selected cells were counted for
each treatment (M0, M1, M2) with respect to the number of immunopositive cells and the
total number of cells. Statistical comparison of the percentage of immunopositive cells between
M0-, M1-, and M2-macrophages was done using a Kruskal-Wallis-Test and pairwise Mann-
Whitney-U-Tests with significance level at p0.05 employing the statistical software pro-
gramme SPSS version 21 for windows, and box plots were depicted using GraphPad Prism 5.0
(GraphPad Software Inc., La Jolla, USA).
Based on the results of the transcriptome investigations (see below), two additional antibod-
ies targeting LXN and MS4A2 (Table 1) were applied on isolated and polarized cells of 3 dogs.
Immunofluorescence was performed analogously to the above mentioned methods. For these
antibodies, blocking was done with normal horse serum. Donkey-anti-goat and donkey-anti-
rabbit antibodies were used as secondary antibodies. Due to the lower n (3 dogs), statistical
comparison of the percentage of immunopositive cells between M0-, M1-, and M2-macro-
phages was done using parametrical tests (one-factorial ANOVA and pairwise t tests) for these
both antibodies.
RNA isolation, microarray hybridization, and low level analysis
For RNA-isolation a separate and analogous in vitro experiment was performed using blood-
derived cells from 6 healthy Beagles. Total RNA was isolated from 6 biological replicates of
Table 1. List of antibodies used for immunofluorescence.
Polarity Antigen Clone Clonality Source Dilution
M1 CD16 LNK16 Monoclonal mouse Abcam‡ 1:20
CD32 AT10 Monoclonal mouse Abcam‡ 1:10
MHC class II Dog 26 Monoclonal rat Helmholtz Zentrum† 1:10
iNOS n.a. Polyclonal rabbit Merck Milipore† 1:50
LXN n.a. Polyclonal goat Biologo * 1:10
M2 MS4A2 n.a. Polyclonal rabbit Biologo * 1:10
CD163 AM-3K Monoclonal mouse TransGenic Inc. k 1:20
CD206 3.29B1.10 Monoclonal mouse BeckmanCoulter Inc.¶ 1:20
Arginase-1 n.a. Polyclonal rabbit Sigma Aldrich§ 1:125
CD, cluster of differentiation; MHC, major histocompatibility complex; iNOS, inducible nitric oxide synthase, LXN, latexin; n.a. = not applicable
‡Cambridge, UK
†kindly provided by Dr. E Kremmer, Institute of Molecular Immunology, Helmholtz Zentrum, Mu¨nchen, German Research Center for Environmental Health
(GmbH), Munich, Germany
†Darmstadt, Germany
kKobe, Japan
¶Krefeld, Germany
§ Taufkirchen, Germany
* Kronshagen, Germany
https://doi.org/10.1371/journal.pone.0183572.t001
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M0-, M1- and M2- macrophages using the RNeasy Mini Kit according to the manufacturer’s
instructions (Qiagen, Hilden, Germany). Quality and integrity of isolated RNA were con-
trolled using the Agilent 6000 RNA Nano Kit and an Agilent Bioanalyzer 2100 (Agilent,
Bo¨blingen, Germany). 200 ng RNA of each sample was amplified and biotin-labeled employ-
ing the Ovation RNA Amplification Kit V2 and the Encore Biotin Module (NuGen, San Car-
los, USA), and hybridized to GeneChip Canine Genome 2.0 arrays (Affymetrix, Santa Clara,
USA) in a rotating oven (45˚C, 16 hours). Subsequently, arrays were washed and stained with
R-phycoerythrin-streptavidin employing Affymetrix GeneChip Fluidics Station 450 (Affyme-
trix, Santa Clara, USA). For scanning, an Affymetrix GeneChip Scanner 3000 (Affymetrix,
Santa Clara, USA) was employed for signal detection. Background adjustment, quantile nor-
malization, and probe-set summarization were performed using the Gene Chip Robust Multi-
chip Average (GC-RMA) algorithm (Bioconductor gcrma for R package, Version 2.3) as
previously described [32]. Raw and processed data sets of the present study are deposited and
publically available in the ArrayExpress database (accession number: E-MTAB-5458; http://
www.ebi.ac.uk/arrayexpress).
Differentially expressed probe sets
Differentially expressed probe sets (DEPs) were detected using the Linear Models for Microar-
ray Data (LIMMA) algorithm, implemented in Babelomics 4.3 (http://babelomics.bioinfo.cipf.
es; [33]), with a maximal false discovery rate (FDR) of 5% (q0.05) according to Benjamini
and Hochberg, followed by post-hoc pairwise comparison of the expression levels of M0-, M1-,
and M2-macrophages [32, 34]. The fold change (FC) was calculated as the ratio of the inverse-
transformed arithmetic means of the log2-transformed expression values. Down-regulations
are shown as negative reciprocal values [34, 35]. Probe sets were annotated with canine gene
symbols and gene names according to the Affymetrix annotation file (release 35; 06. October
2014). A statistical significance filter (LIMMA q0.05) and a fold change filter (FC2.0 or
2.0) were employed to identify differentially expressed probe sets (DEPs) [32]. Differentially
expressed genes (DEGs) were defined as probe sets with a unique canine gene symbol annota-
tion [36].
Functional annotation and hierarchical clustering analysis
Functional enrichment analysis of the DEPs for overexpressed Gene Ontology (GO) terms of
the biological process category and the Kyoto encyclopedia of genes and genomes (KEGG)
was performed using Web-based Gene Set Analysis Toolkit (WebGestalt; http://bioinfo.
vanderbilt.edu/webgestalt/; [37–39]). In order to detect the genes in the pairwise comparison
of M0-, M1-, and M2-macrophages, whose expression was most severely affected, genes with a
FC50.0 or-50.0 were selected and grouped into biological categories [36].
Moreover, unsupervised hierarchical clustering analysis of the DEPs was performed on
log2-transformed data using TM4 MultiExperimentViewer (MeV) with default settings
(Euclidean distance and complete linkage) [40]. The list of DEPs for each of the resulting clus-
ters was functionally analyzed for significant enrichment applying WebGestalt as described
above.
Correlation-based marker gene selection
Based on the transcriptional profile, a subset of probe sets for polarization prediction was
selected using Prophet [41], provided by Babelomics 4.3 [33, 42]. Correlation-based feature
selection was used to pre-select the informative subset of probe sets and K-nearest-neighbors
(KNN) algorithm was used for class prediction with leave-one out error validation [42]. The
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informative subset of 369 probe sets derived from Prophet was further analyzed for the polariza-
tion prediction strength of each individual probe set in three independent “M0 versus M1 and
M2”, “M1 versus M0 and M2”, and “M2 versus M0 and M1” tests using Signature evaluation
tool (SET; [42, 43]). The log2-transformed expression values of three biomarkers, suggested by
Prophet, were additionally statistically compared between M0-, M1-, and M2-macrophages,
employing Kruskal-Wallis-Test and subsequent pairwise Mann-Whitney-U-Tests with signifi-
cance value p0.05.
Comparative evaluation of canine M1-/M2-genes with established
literature-based human and murine orthologous genes
All unique gene symbols, which were up-regulated (FC2; q0.05) in the comparison of M1
vs. M0 and simultaneously up-regulated in the comparison of M1 vs. M2 were defined as
M1-exclusive-genes (n = 404). Likewise, all unique gene symbols, which were up-regulated
(FC 2; q0.05) in the comparison of M2 vs. M0 and simultaneously up-regulated in the com-
parison of M2 vs. M1 were defined as M2-exclusive-genes (n = 700). The gene sets of these
exclusive M1- or M2-associated canine genes were compared with a list of established human
and murine genes specifically associated with M1- or M2-macrophages. This list was generated
based on peer-reviewed publications [4, 27, 31, 44] as previously described [8, 45]. This list was
translated into canine orthologous gene symbols by employing MADgene (http://cardioserve.
nantes.inserm.fr/madtools/madgene/; [46]) and missing orthologous canine official gene sym-
bols were manually added with the help of the web-based “information hyperlinked over pro-
teins” (ihop; http://www.ihop-net.org/UniPub/iHOP/; [47]) as described previously [36].
Summarized, the literature-based gene list included a total number of 65 orthologous canine
genes for M1-macrophages and 58 orthologous canine genes for M2-macrophages [36]. Venn
diagrams (http://bioinfogp.cnb.csic.es/tools/venny/index.html) were used to reveal the inter-
sections between established literature-based genes and the gene sets identified by the present
analysis.
Results
Morphological characterization of polarized canine macrophages
On day 7 in culture, the overall number of cells differed between the three polarities (p = 0.02;
S1 Fig). The number of cells was highest in M2-polarized cells (mean = 135 cells per field),
while M0-macrophages were lowest in number (mean = 30 cells per field). M1-macrophages
had a mean number of 52 cells per field. T tests revealed that the number of M2-macrophages
was significantly higher than M0-macrophages (p = 0.02), while comparisons between M0-
and M1-macrophages and M1-and M2-macrophages failed to reach the level of significance
(p = 0.30 and p = 0.06, respectively).
Morphologically, striking differences between M0-, M1-, and M2-polarized cells were
observed at day 7 in culture by scanning electron microscopy and phase contrast microscopy
(Fig 1). Canine M0-macrophages predominantly appeared as small and roundish cells with an
average size of 8 μm in diameter and no or little cytoplasmic extensions that measured up to
1 μm in length (Fig 1). However, a noteworthy proportion of M0-macrophages (about 25%)
also obtained an amoeboid morphology, which however was predominantly observed in M1
macrophages (Fig 1). The majority of M1-macrophages was amoeboid and had a mean size of
15 μm and numerous fibrillary cytoplasmic processes on the cellular surface that had a length
of up to 5 μm (Fig 1). M2-macrophages appeared as a heterogeneous cell population with a
mixture of 4 different morphologies. Besides roundish and amoeboid macrophages, large
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bipolar spindeloid macrophages were present measuring up to 35 μm that were characterized
by an elongated cell body with cytoplasmic extensions with an average length of 7 μm at both
poles (Fig 1). Moreover, large MNGs appeared that had a mean size of 40 μm with an extensive
cytoplasm and numerous evenly distributed processes that measured up to 7 μm (Fig 1). All-
over, the mean percentage of small/roundish macrophages (morphology 1) was significantly
higher in untreated cultures (M0) compared to polarity 2 at days 5 and 7 (p0.05; Fig 1E). For
amoeboid macrophages (morphology 2), there was a trend towards a higher mean percentage
in polarity 1 compared to polarity 0 at day 5 (p = 0.07) and day 7 (p = 0.06; Fig 1F). The mean
percentage of spindeloid macrophages (morphology 3) was significantly higher in polarity 2 at
day 5 compared to polarity 1 at day 5 (p0.05; Fig 1G). MNGs (morphology 4) were exclu-
sively present in polarity 2, as compared to the polarities 0 and 1 at day 7 (p0.05; Fig 1H).
Phenotypical characterization of polarized canine macrophages
For the phenotypical characterization of canine macrophages, the percentage of immunoposi-
tive cells for selected literature-based M1-/M2-antigens was evaluated in 5 animals and related
to the polarization of cells (polarity 0, 1, 2). Interestingly, except for MHC class II and CD206,
none of the remaining tested antigens (CD16, CD32, iNOS, CD163, and arginase-1) were dif-
ferently expressed between canine M0-, M1-, and M2-macrophages (p-values ranging from
0.101 to 0.691; Kruskal-Wallis-Test; Fig 2).
Fig 1. Polarization-dependent morphological differences in canine M0-, M1-, and M2-macrophage cultures. A) In scanning electron
microscopy, unstimulated macrophages (M0; day 7) obtain a small and roundish morphology, lacking cytoplasmic extensions. B) M1-treated
macrophages (day 7) are characterized by an enlarged amoeboid cell shape with roundish cell bodies and numerous delicate cytoplasmic
extensions on the cellular surface. C; D) M2-treated macrophage cultures (day 7) demonstrate a marked heterogeneity with two dominating cell
types. Large “spindeloid” macrophages with an elongated cell body and cytoplasmic extensions on the apical ends of the cell bodies (C). Second,
in M2-cultures, numerous multinucleated giant cells (MNGs) with abundant cytoplasmic projections on the cellular surface are present (D). E-H)
Dot plot diagrams depicting the morphological changes of macrophage cultures (n = 3) following stimulation (M0, M1, M2) over the time course as
calculated with a mixed ANOVA with post-hoc alpha adjustment (Tukey-Kramer) and significance level at p0.05 (asterisks). E) Small/roundish
macrophages dominate in untreated M0 cell cultures and their relative percentage is significantly higher in M0 when compared to M2 at days 5 and
7. F) Amoeboid macrophages display a statistical trend of predominance in M1 compared to M0 at day 5 and 7. G) The relative percentage of
spindeloid macrophages is significantly increased in M2 at day 5 compared to M1. H) MNGs are almost exclusively observed in M2-macrophages
at the end of the culturing period and their percentage is significantly higher at day 7 in M2 compared to both M0 and M1.
https://doi.org/10.1371/journal.pone.0183572.g001
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The mean percentage of immunopositive cells expressing MHC class II was significantly
higher in M2-macrophages (mean positive cells: 93.64%) when compared to untreated
M0-cells (mean positive cells: 72.22%; p = 0.008). However, there was no statistical difference
in the percentage of positive cells for MHC class II, when M1-macophages (mean positive
cells: 89.92%) were compared to M2-macrophages and M0-macrophages, respectively (Fig 2).
For CD206, the mean percentage of immunopositive cells was highest in M2-macrophages
(mean: 66.54%) as compared to both M0-macrophages (mean: 33.33%; p = 0.008) and M1-mac-
rophages (mean: 28.67%; p = 0.032, Fig 3). No statistical difference was observed between M1-
and M0-macrophages (Fig 3). The results were validated in the microarray data set, which simi-
larly revealed significantly higher expression levels of CD206 in canine M2-macrophages as
compared to both M1- (p = 0.002) and M0-macrophages (p = 0.004; Fig 3).
Differentially expressed genes between M0-, M1-, and M2-polarized
macrophage cultures
One-factorial multigroup analysis of microarray data and fold change criteria identified 6358
probe sets that were differentially expressed in at least one of the three post-hoc pairwise com-
parisons. The total number of DEPs was 3555 in M1 vs. M0, 4831 in M2 vs. M0, and 3141 in
M2 vs. M1, respectively (Table 2). In all pairwise comparisons, the number of up- and down-
regulated probe sets was nearly equally distributed (M1 vs. M0: 1699 up, 1856 down; M2 vs.
M0: 2467 up, 2364 down; M2 vs. M1: 1572 up, 1569 down). Functional annotation of enriched
biological processes in DEPs, up–regulated in the comparison M1 vs. M0, revealed terms for
“organonitrogen compound metabolic process”, “carbohydrate metabolic process”, “carbox-
ylic acid metabolic process”, and “tricarboxylic acid cycle” (Table 2). In contrast, biological
terms in down-regulated DEPs in this comparison reflected terms for “positive regulation of
immune response”, “immune response-regulating signaling pathway”, and “regulation of
innate immune response”. In both comparisons M2 vs. M0 and M2 vs. M1, up-regulated DEPs
displayed significantly enriched gene ontology terms for “M phase of mitotic cell cycle” and
“mitotic spindle organization”. Additionally, in M2 vs. M0 comparison, up-regulated DEPs
were associated with “oxidation-reduction process”, “carboxylic acid metabolic process”, and
“organonitrogen compound metabolic process”, whereas down-regulated DEPs were related
to the biological term “immune response-activating signal transduction”. In the comparisons
M2 vs. M1, down-regulated DEPs were functionally associated to biological terms such as
“response to other organism”, “defense response”, “regulation of lymphocyte activation”, and
“regulation of immune response” (Table 2).
Enriched KEGG-pathways, significantly associated with up-regulated canine DEPs in M1
vs. M0 (1699 DEPs), were functionally related to “metabolic pathways”, “glutathione metabo-
lism”, “steroid biosynthesis”, and “glycolysis/gluconeogenesis”. The comparison M2 vs. M0
(2467 up-regulated DEPs) contained enriched KEGG-pathways for “metabolic pathways”,
Fig 2. Immunofluorescence staining of in vitro cultured canine M0-, M1-, and M2-macrophages labeled with prototypic literature-
based antibodies for the M1- (CD16, CD32, MHC class II, and iNOS) and M2-phenotype (CD163, CD206, and arginase 1), respectively.
A-C) Low to moderate membranous staining of M0-, M1-, and M2-macrophages for CD16. D-F) Likewise, CD32 shows a low to moderate
staining in all three treatment conditions. G-I) M0-, M1-, and M2-macrophages demonstrate a moderate to high membranous staining with
CD163. J-L) Intense membranous staining of M0-, M1-, and M2-macrophages with an anti-MHC class II antibody. M-O) Strong intracytoplasmic
labeling of macrophages in all treatments (polarity 0, 1, 2) for inducible nitric oxide synthase (iNOS). P-R) High intracytoplasmic expression of
arginase 1 in small/roundish, amoeboid, and spindeloid macrophages as well as in multinucleated giant cells (MNGs). a-f) Statistical evaluation
of the mean expression percentages of prototypic M1-/M2-markers evaluated in 5 dogs and related to the polarization state of the macrophages
(polarity 0, 1, 2). Note that, except for MHC class II, none of the remaining tested antigens (CD16, CD32, iNOS, CD163, and arginase-1) were
differently expressed between canine M0-, M1-, and M2-macrophages (* = p0.05; Kruskal-Wallis-Test with pairwise Mann-Whitney-U-Tests).
Scale bars = 100 μm. Nuclear counterstaining with bisbenzimide.
https://doi.org/10.1371/journal.pone.0183572.g002
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“glycolysis/gluconeogenesis”, “propanoate and pyruvate metabolism”, “steroid biosynthesis”,
and “cell cycle”. In the comparison M2 vs. M1 (1572 up-regulated DEPs), enriched KEGG-
pathways included terms for “cell cycle”, “metabolic pathways”, “ribosome biogenesis in
eukaryotes”, and “PPAR signaling pathway”. In contrast, down-regulated DEPs in the three
comparisons were associated with “hematopoietic cell lineage”, “RIG-I-like receptor signaling
pathway”, “T cell receptor signaling pathway”, and “cell adhesion molecules” (M1 vs. M0), “T
cell receptor signaling pathway”, “natural killer cell mediated cytotoxicity”, and “hematopoi-
etic cell lineage” (M2 vs. M0), and “NOD-like receptor signaling pathway”, “osteoclast differ-
entiation”, “Toll-like receptor signaling pathway”, and “B and T cell receptor signaling
pathway” (M2 vs. M1; Table 2).
Genes whose expression was most severely affected (FC50.0 or-50.0) in the pairwise
comparison are depicted in Tables 3, 4 and 5. Fortynine genes fulfilled these filtering criteria in
the M1 vs. M0 contrast (25 up, 24 down), whereas 99 genes were retrieved in the comparison
of M2 vs. M0 (41 up; 58 down). Comparing M2 with M1, 66 genes fulfilled the criteria (32 up;
34 down). Focusing on potentially promising cell surface markers, the pairwise comparison of
three genes encoding for such surface molecules were up-regulated in M1 vs. M0, namely
SUCNR1, SDC4, and CHRNA9, whereas CD209,CD180,KLRG1, COLEC12, and C3AR1were
Fig 3. Phenotypical characterization of canine M0-, M1-, and M2-macrophages. A) Low membranous expression of CD206 antigen by small/
roundish M0-macrophages. B) Moderate membranous staining of amoeboid M1-macrophages for CD206. C) Intense membranous expression of CD206
antigen by M2-macrophages. Scale bars = 100 μm. Nuclear counterstaining with bisbenzimide. D) The mean percentage of CD206-immunopositive cells
is significantly higher in M2-macrophages as compared to both M1- and M0-macrophages (* = p0.05; Kruskal-Wallis-Test with pair-wise Mann-Whitney-
U-Tests). E) The log2-transformed expression values of the probe set encoding for the gene CD206 is similarly significantly higher in M2-macrophages
compared to both M1- and M0-macrophages (* = p0.05; Kruskal-Wallis-Test with pair-wise Mann-Whitney-U-Tests), thus confirming the results of the
immunofluorescence investigation.
https://doi.org/10.1371/journal.pone.0183572.g003
Characterization of polarized canine macrophages
PLOS ONE | https://doi.org/10.1371/journal.pone.0183572 August 17, 2017 11 / 33
down-regulated (Table 3). Comparing M2 vs. M0, nine cell surface makers were up-regulated,
i.e. LYVE1, SUCNR1, CD1e, MRC1, TSPAN7, JAM3, ANTXR1,MS4A2, and CLEC4G (Table 4).
In contrast, a total amount of 18 cell surface marker genes was down-regulated, namely
ITGB8, LY6E, TRDC,NCR3, SELL, SIGLEC1, KLRD1, KLRB1, MPP6, P2RY14, TRBC2,TARP,
FCRLA,KCNK5, P2RX5,NKG7, CD69, and CD7 (Table 4). In the comparison M2 vs. M1, the
up-regulated cell surface marker genes contained 10 terms for FCER1A,CD209, LYVE1,
CLEC4G,COLEC12, JAM3, MS4A2, STAB1, MRC1, and SLC15A1 (Table 5). Down-regulated
cell surface marker genes were P2RY14, SLC39A14, ITGB8, TMEM150C,TMEM176A, and
SLC22A15 (Table 5).
Interestingly, gene expression of CD209markedly decreased in the pairwise comparison of
M1 vs. M0 (FC = -345.12) whereas it was highly up-regulated in the comparison M2 vs. M1
(FC = 335.12). In both comparisons, M2 vs. M0 and M2 vs. M1, genes for LYVE1, MRC1,
MS4A2, JAM3, and CLEC4Gwere up-regulated, whereas genes for ITGB8 and P2RY14 were
down-regulated. SUCNR1 was up-regulated in both M1 vs. M0 and M2 vs. M0.
Table 2. Summarized results of the functional annotation of the pairwise comparisons of differentially expressed probe sets (DEPs) in canine M0-,
M1-, and M2-macrophages.
Pairwise
comparison
Differentially expressed
probe sets
Up-/down-regulated
probe sets
Enriched biological process
categories*
Enriched KEGG pathways*
M1 vs. M0 3555 Up: 1699 • Organonitrogen compound
metabolic process
• Carbohydrate metabolic process
• Tricarboxylic acid cycle
• Metabolic pathways
• Glutathione metabolism
• Steroid biosynthesis
• Glycolysis/Gluconeogenesis
Down: 1856 • Positive regulation of immune
response
• Immune response-regulating
signaling pathway
• Regulation of innate immune
response
• Hematopoietic cell lineage
• RIG-I-like receptor signaling
pathway
• T cell receptor signaling
pathway
• Cell adhesion molecules
M2 vs. M0 4831 Up: 2467 • Oxidation-reduction process
• Carboxylic acid metabolic process
• Organonitrogen compound
metabolic process
• M-phase of mitotic cell cycle
• Metabolic pathways
• Glycolysis/Gluconeogenesis
• Propanoate and pyruvate
metabolism
• Steroid biosynthesis
• Cell cycle
Down: 2364 • Immune response-activating signal
transduction
• T cell receptor signaling
pathway
• Natural killer cell mediated
cytotoxicity
• Hematopoietic cell lineage
M2 vs. M1 3141 Up: 1572 • Mitotic spindle organization • Cell cycle
• Metabolic pathways
• Ribosome biogenesis in
eukaryotes
• PPAR signaling pathway
Down: 1569 • Response to other organism
• Defense response
• Regulation of lymphocyte activation
• Regulation of immune response
• NOD-like receptor signaling
pathway
• Osteoclast differentiation
• Toll-like receptor signaling
pathway
• B and T cell receptor signaling
pathway
* employing Web-based Gene Set Analysis Toolkit (WebGestalt; http://bioinfo.vanderbilt.edu/webgestalt/) with default settings
adjusted p-value0.05
https://doi.org/10.1371/journal.pone.0183572.t002
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Table 3. List and subgrouping of the top hits of highly differentially expressed genes (fold change 50 or -50) in canine M1- vs.
M0-macrophages.
Gene name Gene symbol Fold change
Up-regulated genes
Cell surface markers
Succinate receptor 1 SUCNR1 212.94
Syndecan 4 SDC4 58.61
Cholinergic receptor, nicotinic, alpha 9 (neuronal) CHRNA9 53.74
Enzymes
ADP-ribosylhydrolase like 2 ADPRHL2 535.59
Ceruloplasmin (ferroxidase) CP 161.88
Epoxide hydrolase 2, cytoplasmic EPHX2 119.72
Ectonucleotide pyrophosphatase/phosphodiesterase 2 ENPP2 117.43
Interstitial collagenase-like LOC489428 87.83
E3 ubiquitin-protein ligase NEURL3-like LOC102152163 86.20
NOP2/Sun domain family, member 7 NSUN7 66.00
Nucleoredoxin NXN 64.78
WNK lysine deficient protein kinase 2 WNK2 52.35
Cytokines, chemokines, and their Receptors
Interleukin 6 (interferon, beta 2) IL6 252.32
Chemokine (C-C motif) ligand 22 CCL22 187.96
Chemokine (C-X-C motif) receptor 7 ACKR3 178.18
Interleukin 22 receptor, alpha 2 IL22RA2 116.00
Chemokine (C-X-C motif) ligand 14 CXCL14 108.55
Chemokine (C-C motif) ligand 17 CCL17 95.26
Chemokine (C-C motif) ligand 20 CCL20 67.90
Soluble factors
Chitinase 3-like 1 (cartilage glycoprotein-39) CHI3L1 83.25
Clusterin CLU 66.23
Miscellaneous
Ras homolog family member U RHOU 446.23
Interferon, alpha-inducible protein 6 IFI6 269.13
CXADR-like membrane protein CLMP 213.81
Retinoic acid induced 14 RAI14 118.86
Down-regulated genes
Cell surface markers
CD209 molecule CD209 -345.12
CD180 molecule CD180 -75.00
Killer cell lectin-like receptor subfamily G, member 1 KLRG1 -66.25
Collectin sub-family member 12 COLEC12 -61.81
Complement component 3a receptor 1 C3AR1 -55.16
Enzymes
Carboxypeptidase M CPM -134.50
N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase) NPL -78.98
Cathepsin E CTSE -76.30
Cytokines, chemokines, and their receptors
Chemokine (C-X-C motif) ligand 12 CXCL12 -401.92
Pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) PPBP -100.42
Interleukin 2 IL2 -95.84
(Continued )
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Hierarchical cluster analysis
Unsupervised hierarchical clustering analysis formed 9 different clusters based on similarities
and differences in the expression profile of DEPs (Fig 4). Two out of these 9 clusters had an
expression profile that was visually clearly associated with either the M1- or M2-phenotype
(Fig 4). Functional annotation of these clusters identified that the M1-polarization cluster
(cluster 8) was significantly associated with the biological process “respiratory burst involved
in defense response” (Fig 4). The M2-cluster (cluster 6) was significantly associated with multi-
ple biological processes of mitosis such as “M phase of mitotic cell cycle” and “mitotic spindle
organization” (Fig 4). The genes associated with these M1- and M2-specific clusters are listed
with their particular fold changes in S1 and S2 Tables. The remaining 7 clusters were neither
specific for M1- nor for M2-macrophages and were associated with biological terms like “pep-
tidyl-lysine mono- and dimethylation” (cluster 1), “immune response-activating signal trans-
duction” (cluster 3), “monosaccharide metabolic process”, “organic substance catabolic
process”, “cellular catabolic process” (cluster 4), “response to other organism”, “regulation of
lymphocyte proliferation” (cluster 5), “tRNA aminoacylation for protein translation” (cluster
7), “cytokinesis” and “antigen receptor-mediated signaling pathway” (cluster 9, S3 Table). No
significantly enriched biological terms were identified for cluster 2.
Literature-based gene signatures and marker genes
Intersections of genes exclusively up-regulated in M1 vs. M0 and down regulated in M2 vs. M1
(M1-macrophage genes), as well as genes up-regulated in the comparisons M2 vs. M0 and M2
vs. M1 (M2-macrophage genes) were selected and compared to literature-based markers that
are known to distinguish between human and murine M1- and M2-macrophages (Fig 5A).
Notably, many markers identified in the recent study to be specific for canine M1-polarization
(404 unique genes in total corresponding to 565 probesets, S5 Table) did not match with the
literature-based M1-markers (65 genes). Similarly, predominating numbers of canine M2-
markers (700 unique genes in total corresponding to 1029 probesets, S5 Table) did not match
with the literature-based M2-markers (58 genes; Fig 5A). However, overlapping expression
of genes reflecting M1-polarization state was present for 8 genes, i.e. BIRC3, CCR7,CD80,
Table 3. (Continued)
Gene name Gene symbol Fold change
Interleukin 1 receptor, type II IL1R2 -79.71
Chemokine (C-C motif) receptor 3 CCR3 -51.05
Soluble factors
Lipocalin 2 LCN2 -180.73
CD5 molecule-like CD5L -153.48
Secreted phosphoprotein 2, 24kDa SPP2 -51.92
Miscellaneous
Coagulation factor XIII, A1 polypeptide F13A1 -3305.03
Fatty acid binding protein 4, adipocyte FABP4 -370.34
G protein-coupled receptor 116 GPR116 -130.89
Interferon-induced transmembrane protein 3-like LOC606890 -114.16
Plexin domain containing 2 PLXDC2 -67.07
ADP-ribosylation factor-like 4C ARL4C -56.52
Cyclin J-like CCNJL -54.76
Thrombospondin 1 THBS1 -53.38
https://doi.org/10.1371/journal.pone.0183572.t003
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Table 4. List and subgrouping of the top hits of highly differentially expressed genes (fold change 50 or -50) in canine M2- vs.
M0-macrophages.
Gene name Gene symbol Fold change
Up-regulated genes
Cell surface markers
Lymphatic vessel endothelial hyaluronan receptor 1 LYVE1 322.32
Succinate receptor 1 SUCNR1 151.91
CD1e molecule CD1E 147.40
Mannose receptor, C type 1 MRC1 104.41
Tetraspanin 7 TSPAN7 83.25
Junctional adhesion molecule 3 JAM3 78.46
Anthrax toxin receptor 1 ANTXR1 72.95
Membrane-spanning 4-domains, subfamily A, member 2 MS4A2 54.98
C-type lectin domain family 4, member G CLEC4G 54.14
Enzymes
ADP-ribosylhydrolase like 2 ADPRHL2 614.52
Guanine deaminase GDA 174.44
Ubiquitin-conjugating enzyme E2 C-like LOC481325 151.23
Ribonucleotide reductase M2 RRM2 131.03
Fructose-1,6-bisphosphatase 1 FBP1 57.95
Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) MMP9 56.03
Lipoprotein lipase LPL 52.03
Trimethyllysine hydroxylase, epsilon TMLHE 51.05
3-hydroxybutyrate dehydrogenase, type 2 BDH2 50.68
Cytokines, chemokines, and their receptors
Chemokine (C-C motif) ligand 24 CCL24 1060.82
Chemokine (C-X-C motif) receptor 7 ACKR3 390.67
Chemokine (C-C motif) ligand 17 CCL17 209.36
Chemokine (C-C motif) ligand 13 CCL13 172.58
Interleukin 13 receptor, alpha 2 IL13RA2 170.59
Transforming growth factor, beta 2 TGFB2 61.84
Soluble factors
Nephronectin NPNT 444.07
Norrie disease (pseudoglioma) NDP 213.72
Endothelin 1 EDN1 115.81
Cystatin 9 (testatin) CST9 58.21
Miscellaneous
Sodium channel, voltage-gated, type II, beta subunit SCN2B 1061.28
Caldesmon 1 CALD1 224.66
CXADR-like membrane protein CLMP 169.27
SHC SH2-domain binding protein 1 SHCBP1 117.77
Dynamin 1 DNM1 112.78
NACC family member 2, BEN and BTB (POZ) domain containing NACC2 110.49
Retinoic acid induced 14 RAI14 84.35
Scinderin SCIN 71.66
Kinesin family member 23 KIF23 66.78
Kinesin family member 11 KIF11 64.20
Cfa-mir-125b-2 cfa-mir-125b-2 58.78
AHNAK nucleoprotein AHNAK 57.19
(Continued )
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Table 4. (Continued)
Gene name Gene symbol Fold change
NUF2, NDC80 kinetochore complex component NUF2 54.62
Down-regulated genes
Cell surface markers
Integrin, beta 8 ITGB8 -199.37
Lymphocyte antigen 6 complex, locus E LY6E -116.70
T cell receptor delta constant TRDC -112.73
Natural cytotoxicity triggering receptor 3 NCR3 -105.99
Selectin L SELL -95.45
Sialic acid binding Ig-like lectin 1, sialoadhesin SIGLEC1 -91.39
Killer cell lectin-like receptor subfamily D, member 1 KLRD1 -87.12
Killer cell lectin-like receptor subfamily B, member 1 KLRB1 -74.56
Membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6) MPP6 -72.60
Purinergic receptor P2Y, G-protein coupled, 14 P2RY14 -71.69
T cell receptor beta constant 2 TRBC2 -64.26
TCR gamma alternate reading frame protein TARP -62.39
Fc receptor-like A FCRLA -60.06
Potassium channel, subfamily K, member 5 KCNK5 -58.16
Purinergic receptor P2X, ligand-gated ion channel, 5 P2RX5 -58.16
Natural killer cell group 7 sequence NKG7 -57.26
CD69 molecule CD69 -54.53
CD7 molecule CD7 -52.57
Enzymes
Interferon stimulated exonuclease gene 20kDa ISG20 -514.04
Prostaglandin E synthase PTGES -382.20
Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial CMPK2 -266.50
Granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) GZMA -131.27
Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) GZMB -130.63
Hexokinase 3 (white cell) HK3 -127.10
Ubiquitin specific peptidase 18 USP18 -81.72
Phospholipase A1 member A PLA1A -72.65
Cathepsin E CTSE -72.13
GTP cyclohydrolase 1 GCH1 -66.29
Chymase 1, mast cell CMA1 -61.45
Phospholipid scramblase 1-like LOC611500 -61.09
Cytokines, chemokines, and their receptors
Chemokine (C-X-C motif) ligand 12 CXCL12 -417.05
Interleukin 2 IL2 -195.40
Interleukin 7 receptor IL7R -66.71
Transforming growth factor, beta receptor III TGFBR3 -50.94
Soluble factors
Lipocalin 2 LCN2 -217.74
Adrenomedullin ADM -100.37
Miscellaneous
Radical S-adenosyl methionine domain containing 2 RSAD2 -559.34
Interferon-induced transmembrane protein 3-like LOC606890 -435.57
ISG15 ubiquitin-like modifier ISG15 -254.32
Apolipoprotein L, 5 APOL5 -200.23
(Continued )
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IL15RA, IL23A, INHBA, NAMPT, and SLC2A6. For canine M2-polarization, 11 genes matched
reported expression in human and murine M2-macrophages, i.e. CCL24,CCL13, FCER1A,
FN1, EGR2, CA2, LIPA, SLC4A7, CD163,ADK, and FGL2 (Fig 5A). Conflicting results were
present for the genes P2RY14, TGFBR2, and TPST2, which were expected as M2-markers
based on the literature but were differentially up-regulated in canine M1-macrophages. Fur-
thermore, PIK3CB was up-regulated by both canine M1- and M2-macrophages in the present
study. The differentially expressed genes of the intersections, which are not namely mentioned
in Fig 5A are listed in S4 Table. The top 50 candidate canine M1- and M2-macrophage genes,
as defined above, are given in Tables 6 and 7. The full lists of canine probesets, corresponding
to the 404 unique M1 genes and 700 unique M2 genes are shown in S5 Table.
Biomarker selection
In a hypothesis-driven approach, polarization specific prediction markers were detected with
Prophet using the microarray data of unstimulated macrophages (M0), M1-, and M2-macro-
phages [41, 42]. 369 probe sets were identified by the correlation-based feature selection algo-
rithm of Prophet that discriminated between M0-, M1-, and M2-polarity, using the KNN
algorithm with 100% correct predictions. Subsequent “one versus all” analyses using SET to
create ranked lists of genes, based on their potential to serve as biomarker for M1- or M2-mac-
rophages were performed (S6 Table; [43]). The highest scoring probe set differentiating M1-
from M0- and M2-macrophages was CfaAffx.14358.1.S1_at, annotated as latexin (LXN),
which was up-regulated in M1-macrophages, exhibiting a prediction-accuracy for the M1-phe-
notype of 100%. Additionally, the probe set ID’s occupying the ranks 2 to 4 (Cfa.5195.1.
A1_s_at, Cfa.5195.1.A1_at, Cfa.14007.1.A1_x_at) were similarly annotated to LXN (S6 Table).
Analysis of the expression data of CfaAffx.14358.1.S1_at revealed a relatively high expression
in all three polarities with a significantly higher expression in M1-macrophages as compared
to M0- and M2-macrophages (pairwise Mann-Whitney-U-Tests; p = 0.02, Fig 5B). For the
comparison of M2 versus M0 and M1, the highest scoring probe set was Cfa.3662.1.S1_at,
Table 4. (Continued)
Gene name Gene symbol Fold change
Fatty acid binding protein 4, adipocyte FABP4 -182.17
Interferon-induced protein with tetratricopeptide repeats 1 IFIT1 -142.72
Interferon regulatory factor 4-like LOC609817 -118.68
Carcinoembryonic antigen-related cell adhesion molecule 25 CAECAM1 -113.27
Interferon regulatory factor 7 IRF7 -102.93
OCIA domain containing 2 OCIAD2 -100.84
Piwi-like RNA-mediated gene silencing 4 PIWIL4 -97.75
Synaptotagmin-like 3 SYTL3 -94.94
Testis expressed 14 TEX14 -92.58
Myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) MX1 -91.32
Structural maintenance of chromosomes flexible hinge domain containing 1 SMCHD1 -84.97
Interferon-induced transmembrane protein 1-like LOC475935 -83.91
eukaryotic peptide chain release factor GTP-binding subunit ERF3B-like LOC480921 -74.06
Lactotransferrin LTF -72.08
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 DDX58 -69.54
TNFAIP3 interacting protein 3 TNIP3 -58.03
Syntrophin, beta 1 (dystrophin-associated protein A1, 59kDa, basic component 1) SNTB1 -55.46
Src kinase associated phosphoprotein 1 SKAP1 -50.58
https://doi.org/10.1371/journal.pone.0183572.t004
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Table 5. List and subgrouping of the top hits of highly differentially expressed genes (fold change 50 or -50) in M2- vs. M1-macrophages.
Gene name Gene symbol Fold change
Up-regulated genes
Cell surface markers
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide FCER1A 376.89
CD209 molecule CD209 335.12
Lymphatic vessel endothelial hyaluronan receptor 1 LYVE1 321.11
C-type lectin domain family 4, member G CLEC4G 183.13
Collectin sub-family member 12 COLEC12 181.04
Junctional adhesion molecule 3 JAM3 145.24
Membrane-spanning 4-domains, subfamily A, member 2 MS4A2 137.95
Stabilin 1 STAB1 127.60
Mannose receptor, C type 1 MRC1 52.68
Solute carrier family 15 (oligopeptide transporter), member 1 SLC15A1 52.03
Enzymes
Fructose-1,6-bisphosphatase 1 FBP1 149.73
Uronyl-2-sulfotransferase UST 85.20
Alanyl (membrane) aminopeptidase ANPEP 82.13
Lipoprotein lipase LPL 57.39
Cytokines, chemokines, and their receptors
Chemokine (C-C motif) ligand 24 CCL24 1050.11
Transforming growth factor, beta 2 TGFB2 66.97
Soluble factors
CD5 molecule-like CD5L 209.01
Secreted phosphoprotein 2, 24kDa SPP2 121.14
Nephronectin NPNT 105.07
Secretogranin V (7B2 protein) SCG5 82.69
Complement component 3 C3 67.78
Cystatin 9 (testatin) CST9 58.53
Miscellaneous
Coagulation factor XIII, A1 polypeptide F13A1 1309.86
Sodium channel, voltage-gated, type II, beta subunit SCN2B 1120.45
Dynamin 1 DNM1 247.10
Caldesmon 1 CALD1 239.74
Rho GTPase activating protein 6 ARHGAP6 147.58
Fibronectin 1 FN1 141.81
Cfa-mir-125b-2 cfa-mir-125b-2 103.61
Plexin domain containing 2 PLXDC2 71.70
Transforming growth factor, beta-induced, 68kDa TGFBI 59.20
G protein-coupled receptor 116 GPR116 51.83
Down-regulated genes
Cell surface markers
Purinergic receptor P2Y, G-protein coupled, 14 P2RY14 -344.22
Solute carrier family 39 (zinc transporter), member 14 SLC39A14 -200.01
Integrin, beta 8 ITGB8 -134.58
Transmembrane protein 150C TMEM150C -103.02
Transmembrane protein 176A TMEM176A -78.17
Solute carrier family 22, member 15 SLC22A15 -58.69
Enzymes
(Continued )
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annotated as membrane-spanning 4-domains, subfamily A, member 2 (MS4A2, S6 Table). This
probe set was up-regulated in M2-macrophages and displayed a prediction accuracy of 100%
for this phenotype. Statistical evaluation with pairwise Mann-Whitney-U-Tests underlined a
low expression of MS4A2 in M0- and M1-macrophages, but a significantly higher expression
in M2-macrophages (p = 0.02, Fig 5C).
Testing of antibodies for the detection of predicted biomarkers
In order to test, whether the biomarkers predicted to distinguish between canine M0-, M1-,
and M2-macrophages during the transcriptome investigations are also mirrored by altered
protein expression, an additional experiment using blood from 3 dogs was performed. The
cells were isolated and polarized as described and labeled with antibodies targeting MS4A2
and LXN (Table 1). There was protein expression in canine macrophages in vitro for both mol-
ecules (Fig 6). However, the percentage of cells labeled with an antibody against MS4A2
showed no differences between M0-, M1-, and M2-macrophages (p = 0.117; Fig 6). The
Table 5. (Continued)
Gene name Gene symbol Fold change
Prostaglandin E synthase PTGES -1274.66
Epoxide hydrolase 2, cytoplasmic EPHX2 -222.01
Interferon stimulated exonuclease gene 20kDa ISG20 -187.95
Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) PTGS2 -183.48
E3 ubiquitin-protein ligase NEURL3-like LOC102152163 -156.11
Indoleamine 2,3-dioxygenase 2 IDO2 -127.88
STEAP family member 4 STEAP4 -92.42
Ceruloplasmin (ferroxidase) CP -90.30
Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) GZMB -69.42
Phospholipase A2, group XVI-like LOC476045 -57.39
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial CMPK2 -57.00
WNK lysine deficient protein kinase 2 WNK2 -52.30
Interleukin-1 receptor-associated kinase 3 IRAK3 -50.40
Cytokines, chemokines, and their receptors
Chemokine (C-X-C motif) receptor 3 CXCR3 -140.97
Chemokine (C-C motif) ligand 20 CCL20 -119.64
Interleukin 6 (interferon, beta 2) IL6 -69.50
Tumor necrosis factor TNF -55.63
Soluble factors
Complement component 2 C2 -78.67
Miscellaneous
Peptidase inhibitor 3, skin-derived PI3 -235.52
TNFAIP3 interacting protein 3 TNIP3 -178.37
Ras homolog family member U RHOU -168.17
Radical S-adenosyl methionine domain containing 2 RSAD2 -82.43
Cochlin COCH -70.23
Interferon, alpha-inducible protein 6 IFI6 -68.46
multiple C2 domains, transmembrane 2 MCTP2 -66.09
Fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) FSCN1 -58.64
Interferon regulatory factor 4-like LOC609817 -50.92
ISG15 ubiquitin-like modifier ISG15 -50.28
https://doi.org/10.1371/journal.pone.0183572.t005
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percentage of positive cells for LXN was significantly higher in both M1-and M2-macrophages
as compared to M0-macrophages (p = 0.02 and p = 0.01, respectively); however, there was no
difference in the percentage of LXN-immunopositive cells between M1- and M2-macrophages
(p = 0.06; Fig 6).
Fig 4. Hierarchical clustering analysis. Unsupervised hierarchical clustering analysis of the median centered, log2-transformed expression values of
6358 differentially expressed probe sets in canine polarized macrophages as obtained by TM4 MultiExperimentViewer with default settings (Euclidean
distance; complete linkage), depicted on a color scale from red (relatively high expression) to green (relatively low expression). A) The analysis identified 9
distinct clusters (I-IX) based on similarities as well as differences in the expression intensity of canine polarized macrophages. Two out of these 9 clusters
(VIII and VI) visually displayed an expression profile that was clearly associated with either the M1- or M2-phenotype. B) Functional annotation of the
M1-cluster (magnified from A) using Web-based Gene Set Analysis Toolkit (WebGestalt) identified the enriched biological process category “respiratory
burst” (adjusted p-value0.05). C) The M2-cluster (magnified from A) is associated with enriched biological GO terms such as “M phase of mitotic cell
cycle” and “mitotic spindle organization” (adjusted p-value0.05).
https://doi.org/10.1371/journal.pone.0183572.g004
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Fig 5. Comparative evaluation of canine M1- and M2-associated differentially expressed genes (M1 = 404; M2 = 700) with
established literature-based human and murine orthologous genes (A) and detection of polarization-specific biomarkers
employing supervised clustering with a K-nearest-neighbors algorithm and correlation-based feature selection using Prophet
(B, C). A) The Venn diagram depicts the numbers and intersections of differential and common canine M1- and M2-genes with literature-
based human and murine genes. The majority of literature-based M1- (65 genes = 57+8) and M2-markers (58 genes = 44+11+3) did not
comply with the present microarray data upon canine macrophages. However, overlapping expression of 8 genes for the M1-phenotype
and 11 genes for the M2-phenotype was identified. The genes of the intersections, not specifically mentioned in the figure, are listed in S4
Table B) Biomarker selection detected 4 highly specific probe sets for annotated by the mammalian carboxypeptidase inhibitor latexin
(LXN) to be highly correlated to the M1-phenotype. The boxplots depict the significantly enhanced log2-transformed expression values for
LXN in M1-macrophages as compared to both M0- and M2-macrophages (p = 0.002), as well as between M0- and M2-macrophages
(p = 0.002). C) For the M2-phenotype, the most significant predicted biomarker was high affinity receptor for IgE, i.e. membrane-spanning
4-domains, subfamily A, member 2 (MS4A2). The expression data of M2-macrophages show significantly higher log2-transformed
expression values as compared to both M0- and M1-macrophages (p = 0.002) as well as between M0- and M1-macrophages (p = 0.002).
Asterisks indicate significance (Kruskal-Wallis-Test with subsequent pairwise Mann-Whitney-U-Tests).
https://doi.org/10.1371/journal.pone.0183572.g005
Characterization of polarized canine macrophages
PLOS ONE | https://doi.org/10.1371/journal.pone.0183572 August 17, 2017 21 / 33
Table 6. Top 50 candidate M1-macrophage associated probesets, which were upregulated in M1- vs. M0-macrophages and simultaneously down-
regulated in M2- vs. M1-macrophages.
Probe Set ID Gene Symbol Fold change M1 vs. M0 Fold change M2 vs. M1
Cfa.12190.1.A1_at PTGES 3.34 -1274.66
CfaAffx.30585.1.S1_s_at PTGES 4.99 -1136.51
CfaAffx.30585.1.S1_at PTGES 4.94 -517.22
CfaAffx.927.1.S1_at P2RY14 4.80 -344.22
Cfa.20456.1.S1_at IFI6 269.13 -284.48
CfaAffx.15155.1.S1_s_at PI3 27.22 -235.52
Cfa.574.1.A1_at EPHX2 119.72 -222.01
Cfa.18083.1.S1_s_at SLC39A14 15.89 -212.19
CfaAffx.14855.1.S1_s_at SLC39A14 13.48 -200.01
Cfa.3449.1.S1_s_at PTGS2 27.78 -183.48
Cfa.15554.1.A1_at TNIP3 3.07 -178.37
Cfa.9253.1.A1_at RHOU 446.23 -168.17
Cfa.12477.1.A1_at LOC102152163 86.20 -156.11
Cfa.16339.1.S1_at CXCR3 5.70 -140.97
Cfa.10779.1.A1_at IDO2 28.65 -127.88
CfaAffx.13394.1.S1_s_at EPHX2 110.24 -122.12
Cfa.15812.1.S1_at CCL20 67.90 -119.64
Cfa.1856.1.S1_at TMEM150C 40.36 -103.02
Cfa.2878.1.A1_s_at CP 425.52 -96.02
CfaAffx.3697.1.S1_at STEAP4 11.45 -92.42
CfaAffx.13209.1.S1_s_at CP 161.88 -90.30
Cfa.8846.1.A1_s_at C2 /// CFB 4.39 -78.67
CfaAffx.7919.1.S1_at TMEM176A 19.58 -78.17
CfaAffx.1718.1.S1_at TNF 47.17 -71.34
Cfa.3528.1.S1_s_at IL6 252.32 -69.50
Cfa.20456.1.S1_s_at IFI6 68.64 -68.46
CfaAffx.17110.1.S1_s_at MCTP2 2.69 -66.09
CfaAffx.15348.1.S1_at SLC22A15 15.67 -58.69
CfaAffx.24565.1.S1_at FSCN1 35.83 -58.64
Cfa.12164.1.A1_at LOC476045 5.65 -57.39
Cfa.54.1.S1_s_at TNF 47.20 -55.63
Cfa.11870.1.A1_at PI3 17.25 -52.33
Cfa.4359.1.S1_at WNK2 52.35 -52.30
CfaAffx.1510.1.S1_s_at IRAK3 10.70 -50.40
CfaAffx.15202.1.S1_s_at SDC4 58.61 -49.56
CfaAffx.1352.1.S1_s_at IL22RA2 116.00 -48.48
CfaAffx.26233.1.S1_s_at CXCR3 32.55 -47.23
CfaAffx.17136.1.S1_s_at MCTP2 6.25 -46.94
CfaAffx.24086.1.S1_at KMO 23.66 -46.48
CfaAffx.15086.1.S1_s_at BMP1 43.14 -43.31
CfaAffx.261.1.S1_at HCAR3 13.88 -42.20
Cfa.18962.1.S1_s_at SGK1 20.11 -39.12
Cfa.3719.1.S1_s_at QPCT 22.78 -38.99
Cfa.4926.1.A1_s_at LOC476045 5.41 -37.14
CfaAffx.6260.1.S1_at C18H7orf10 43.19 -36.13
Cfa.6458.1.A1_s_at C2 /// CFB 5.05 -36.01
(Continued )
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Discussion
The current investigation is the first report upon the properties of canine polarized macro-
phages in vitro with a special emphasis on the establishment of unique distinctive gene signa-
tures. Even though in vitro data on macrophage polarization doubtlessly cannot be simply
extrapolated to in vivo situations and the paradigm of M1-/M2-polarization represents a sim-
plified approach, which depicts only two extremes of macrophage heterogeneity [8, 48–50],
this initial reductionistic in vitro approach will provide a basis for future investigations on the
role of macrophage polarization in both healthy and diseased dogs.
Striking morphological differences were observed between canine M0-, M1-, and M2-mac-
rophages, which are most probably attributed to direct effects of cytokine stimulation. Similar
to observations in other species [51–54], M1-macrophage cultures appeared to dominantly
adapt an amoeboid morphology, although a significant proportion of M0-macrophages also
obtained such an amoeboid morphology. Notably, M2-cultures were rather heterogeneous
including spindeloid cells and MNGs, which is in line with previous observations in human
and murine bone marrow- and blood-derived M2-macrophages [51–54]. Interestingly, stimu-
lation of macrophages with IL-4 and IL-13 together with colony stimulation factors can lead to
the formation of MNGs [55–58]. The recent observation of MNG formation, exclusively in
canine M2-cultures, is consistent with reports from other species [44, 57, 59].
A variety of different phenotypic markers has been proposed for the differentiation of
human and murine M1- and M2-macrophages [4, 31]. Even though a multitude of antibodies
targeting immune cells including macrophages is known to cross-react with canine antigens
[60–63], commercially available antibodies explicitly designed for the use on canine cells and
tissues are frequently not available. The prototypical literature-based M1-markers CD16, CD32,
and iNOS and the M2-markers CD163 and arginase-1 were demonstrated to be inappropriate
for the immunophenotypic discrimination of M0-, M1-, and M2-polarization states in canine
macrophages in the present study. This may in part be explained by interspecies differences [64,
65]. For instance, following classical stimulation with pro-inflammatory cytokines, murine mac-
rophages produce NO, whereas human macrophages nearly lack synthesis of NO in response to
classically activating stimuli [66, 67]. Moreover, arginase-1 has been reported as a prototype
marker for murine M2-macrophages, which is however inappropriate for the detection of
human M2-macrophages [13, 44, 68, 69]. Based on the present observations, canine macro-
phages may thus share closer similarities with human than murine macrophages, thus underlin-
ing the role of dogs in translational research. Similar to the immunofluorescence data, and
supporting the results of the immunophenotyping, expression values for all probesets annotated
with the canine genes NOS2 (2 probesets) and ARG1 (3 probesets), which encode iNOS and
arginase-1, respectively, also lacked differences in their expression values between M0-, M1-,
and M2-macrophages (data available under accession number: E-MTAB-5458; http://www.ebi.
ac.uk/arrayexpress). MHC class II is sometimes regarded as a marker for classically activated
M1 macrophages [70]; however, a substantial fundus of literature also indicates MHC class II as
a pan-macrophage marker, which is expressed on both M1 and M2 macrophages in mice and
Table 6. (Continued)
Probe Set ID Gene Symbol Fold change M1 vs. M0 Fold change M2 vs. M1
Cfa.8282.1.A1_s_at KBTBD7 3.64 -35.38
CfaAffx.8143.1.S1_at KBTBD7 2.59 -35.14
Cfa.21252.1.S1_s_at ENPP2 188.74 -34.85
CfaAffx.16422.1.S1_s_at CCL20 33.43 -34.83
https://doi.org/10.1371/journal.pone.0183572.t006
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Table 7. Top 50 candidate M2-macrophage associated probesets, which were upregulated in M2- vs. M0-macrophages and simultaneously upre-
gulated in M2- vs. M1-macrophages.
Probe Set ID Gene Symbol Fold change M2 vs. M0 Fold change M2 vs. M1
Cfa.11125.1.A1_at SCN2B 1061.28 1120.45
Cfa.15823.1.S1_at CCL24 1060.82 1050.11
CfaAffx.18273.1.S1_at FCER1A 35.63 922.72
CfaAffx.20721.1.S1_s_at CCL24 819.06 819.06
Cfa.17541.1.S1_s_at FBP1 160.02 748.69
CfaAffx.2850.1.S1_s_at FBP1 57.95 422.21
Cfa.3663.1.A1_s_at FCER1A 21.07 376.89
Cfa.3707.1.A1_at FN1 12.68 360.42
CfaAffx.12229.1.S1_at LYVE1 322.32 321.11
Cfa.10966.1.A1_at DNM1 112.78 247.10
Cfa.6272.1.S1_at CALD1 224.66 239.74
CfaAffx.1504.1.S1_s_at UST 7.71 226.47
Cfa.2693.1.A1_at LOC102152647 194.28 194.28
Cfa.3707.1.A1_s_at FN1 7.26 188.32
CfaAffx.28024.1.S1_at CLEC4G 54.14 183.13
CfaAffx.16206.1.S1_at MS4A2 110.05 167.77
Cfa.6369.1.A1_at FBP1 26.98 149.73
Cfa.20346.1.S1_at ARHGAP6 37.99 147.58
Cfa.1705.1.A1_at JAM3 78.46 145.24
Cfa.3662.1.S1_at MS4A2 54.98 137.95
Cfa.19567.1.S1_at UST 8.05 120.81
CfaAffx.16206.1.S1_s_at MS4A2 76.56 108.61
Cfa.3774.1.A1_s_at ANPEP 25.55 105.73
Cfa.14465.1.S1_at NPNT 444.07 105.07
Cfa.688.1.S1_at cfa-mir-125b-2 58.78 103.61
CfaAffx.7700.1.S1_s_at MRC1 136.99 89.14
Cfa.2468.1.A1_at UST 6.54 85.20
Cfa.10794.1.A1_at SCG5 6.75 82.69
Cfa.20798.1.S1_at ANPEP 14.09 82.13
CfaAffx.14701.1.S1_s_at STAB1 4.00 81.41
CfaAffx.28463.1.S1_at C3 36.53 76.45
Cfa.12240.1.A1_at C3 44.14 67.78
CfaAffx.16904.1.S1_s_at TGFB2 61.84 66.97
CfaAffx.7365.1.S1_at CST9 58.21 58.53
CfaAffx.15901.1.S1_s_at LPL 52.03 57.39
CfaAffx.7698.1.S1_at MRC1 104.41 52.68
Cfa.78.1.S1_s_at SLC15A1 14.65 52.03
CfaAffx.27914.1.S1_s_at IL13RA2 170.59 46.70
Cfa.19638.1.S1_s_at TMLHE 51.05 45.55
CfaAffx.22229.1.S1_at GPR34 6.30 42.39
CfaAffx.21392.1.S1_s_at FKBP7 25.81 40.60
CfaAffx.19151.1.S1_s_at ADCY4 14.07 39.02
Cfa.11222.1.A1_s_at FAM185A 23.07 38.03
Cfa.10053.1.A1_at RAB40B 48.86 37.88
CfaAffx.24797.1.S1_at EPHX1 3.75 36.82
Cfa.1930.1.S1_at MRC1 25.70 36.76
(Continued )
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humans without discriminating between both phenotypes [4, 7, 68]. Concordantly, the immu-
nofluorescence data demonstrated that MHC class II was found to distinguish between canine
M2- and M0-macrophages with a lower expression in the latter (Fig 3). In fact, it is well known
that IL-4 acts as a potent activator of macrophages and induces an up-regulation of MHC class
II [23, 71–75]. However, it must be critically considered that MHC class II appeared inappropri-
ate for the differentiation of canine M0- and M1-macrophages on the protein level, which con-
tradicts reported up-regulation of MHC class II on M1 macrophages [7]. Whether these
differences are attributed to true species effects or whether the low number of investigated ani-
mals and the quantification method (immunofluorescence) are responsible for not reaching the
level of significance remains to be determined.
Conclusively, it is unlikely that a single antibody will be sufficient to specifically detect
canine M1- and M2-macrophages in vivo. Due to the paucity of commercially available anti-
bodies detecting canine antigens this will probably also involve the generation of antibodies
targeting canine epitopes.
The present study thus aimed to set up a transcriptomic basis that should encourage future
attempts to establish a broader antibody panel against antigens, which are predicted to poten-
tially represent discriminating markers for canine macrophage phenotypes. Interestingly, in
the present study, CD206 was among the top regulated genes of canine M2 macrophages on
the transcriptome level, and the results of the immunophenotyping also validated CD206 as a
promising marker for canine M2 polarized macrophages. This implies that CD206 might con-
stitute a conserved marker, which is appropriate for labeling M2-macrophages in various spe-
cies including the dog [4, 27, 31, 72, 76]. However, a limitation of the present study is that the
suitability of markers identified in the transcriptome analyses either still needs to be verified
on the protein level or produced partially conflicting results in the immunofluorescence inves-
tigations (i.e. CD163, LXN, and MS4A2).
For M1-associated up-regulated genes, multiple metabolic pathways such as “steroid bio-
synthesis”, and “glycolysis/gluconeogenesis” demonstrated to be enriched in the functional
annotation of microarray data. Human and murine monocyte to macrophage differentiation
has previously been shown to go along with profound changes in the lipid metabolism as a pre-
requisite for phagocytosis [77]. Moreover, in the hierarchical clustering analysis, the M1-spe-
cific cluster was functionally annotated to biological processes involved in “respiratory burst”.
M1 macrophages produce a variety of pro-inflammatory mediators including ROS, whereas in
contrast, IL-4 inhibits the respiratory burst [78].
Enriched terms related to the peroxisome proliferator activated receptor (PPAR) signaling
pathway were retrieved for the comparison of M2 vs. M1 up-regulated genes. PPARγ is a mem-
ber of the nuclear receptor superfamily with potent anti-inflammatory properties and regula-
tory functions in fatty acid metabolism [79–82]. Interestingly, PPARγ agonists such as
rosiglitazone induce an alternative M2a-activation state in murine macrophages and have
been used as neuroprotective agents [83, 84]. Pharmacological approaches, designed to
enhance M2-dominated immune responses may thus similarly represent a promising tool in
canine diseases.
Table 7. (Continued)
Probe Set ID Gene Symbol Fold change M2 vs. M0 Fold change M2 vs. M1
Cfa.3367.1.A1_at TGFB2 36.49 36.58
Cfa.15824.1.S1_at CCL13 172.58 34.71
Cfa.14297.1.A1_s_at MAOB 33.75 33.75
Cfa.12621.1.A1_at LRP4 7.01 33.01
https://doi.org/10.1371/journal.pone.0183572.t007
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Interestingly, multiple biological processes related to an enhanced cell cycle were enriched
in canine M2-macrophages as compared to both M0- and M1-macrophages. IL-4 has previ-
ously been reported to induce local macrophage proliferation in the context of chronic inflam-
mation [59]. Moreover, human monocyte to macrophage differentiation in the presence of
M-CSF is associated with a dramatic regulation of multiple cell-cycle genes [44]. The
Fig 6. Protein expression of the predicted biomarkers latexin and MS4A2 in canine M0-, M1-, and M2-macrophages. A) Expression of latexin in
non-stimulated canine M0-macrophages. B) Expression of latexin in canine M1-macrophages. C) Expression of latexin in canine M2-macrophages. D)
Expression of MS4A2 in canine M0-macrophages. E) Expression of MS4A2 in canine M1-macrophages. F) Expression of MS4A2 in canine
M2-macrophages. A-F) Scale bars = 100 μm. Nuclear counterstaining with bisbenzimide. G) Dot plots illustrating a significantly higher percentage of
immunopositive cells in canine M1- and M2-macrophages as compared to M0-macrophages (One-factorial ANOVA with group-wise t-tests,
astrerisk = p<0.05). H) Dot plot showing lack of statistical differences in the percentage of immunopositive cells for MS4A2 in canine M0-, M1-, and
M2-macrophages.
https://doi.org/10.1371/journal.pone.0183572.g006
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transcriptomic link to enhanced cell cycle and proliferation is probably also reflected by the
higher cell number of M2-macrophages in the present study as compared to M0-macrophages
(S1 Fig).
Comparison of the canine transcriptome data with published murine and human prototype
markers demonstrated a relatively low overlap. This confirms recent reports on marked inter-
species differences between polarized macrophages [13] and suggests that some properties of
polarized macrophages are unique to the dog, demonstrating that reported literature-based
markers cannot simply be transferred to another species.
Based on this observation we sought to predict novel transcriptomic markers using a
hypothesis-driven approach. Using a correlation-based algorithm, the carboxypeptidase inhib-
itor latexin (LXN) [85–88] was retrieved for canine M1-macrophages. Though LXN-expression
by murine macrophages upon pro-inflammatory stimulation has been demonstrated [85],
LXN has so far not been proposed as a marker for M1-macrophages in the literature for any
species. For the canine M2-phenotype, the high-affinity receptor for IgE membrane-spanning
4-domains, subfamily A, member 2 (MS4A2) was predicted to represent the most powerful bio-
marker. Interestingly, other members of the molecule family, i.e. MS4A4A and MS4A6A, have
been previously shown to be associated with M2-polarization [4, 44, 89]. In an attempt to vali-
date LXN and MS4A2 as markers for canine macrophages, we demonstrated that MS4A2
showed no differences in the percentage of immunopositive cells between the three conditions.
The percentage of immunopositive cells for LXN was higher in both M1- and M2-macro-
phages as compared to M0-macrophages. However, similar to MS4A2, LXN failed to distin-
guish between canine M1- and M2-macrophages. Thus, similar to CD163, the protein data did
not accurately mirror the transcriptomic prediction. This could be attributed to conflicting dif-
ferences between RNA- and protein level for these molecules. However, the low number of
dogs tested and the fact that low level differences in protein expression may not be detected by
immunofluorescence have certainly influenced the statistical power and sensitivity, and thus
future validating experiments both in canine tissues and in vitro remain to be performed.
Supporting information
S1 Fig. Dot plot diagrams depicting differences in the absolute number of cells per field
(200x) in canine M0-, M1-, and M2-macrophages derived from 3 dogs on day 7 in culture.
One-factorial ANOVA with group-wise t tests reveals a significantly higher number of cells in
M2-polarized macrophages as compared to non-stimulated (M0)-macrophages (p0.05;
asterisk).
(TIF)
S1 Table. List of the genes included in the M1-associated cluster of the hierarchical cluster-
ing analysis (refer to Fig 3).
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S2 Table. List of the genes included in the M2-associated cluster of the hierarchical cluster-
ing analysis (refer to Fig 3).
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S3 Table. Overview on retrieved enriched gene ontology biological processes and KEGG
pathways of the clusters, resulting from the hierarchical clustering analysis (refer to Fig 3).
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S4 Table. List for the intersections of differentially expressed genes in the comparison of
literature-based human and murine markers with canine M1- and M2-associated genes as
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retrieved by the present study (refer to Fig 4). Excel table.
(XLSX)
S5 Table. Lists of differentially expressed M1- and M2-macrophage associated probesets
with fold change. Sheet 1 depicts all genes, which were upregulated in M1- vs. M0-macro-
phages and simultaneously downregulated in M2- vs M1-macrophages (i.e. canine M1-macro-
phage genes). Sheet 2 shows all genes, which were upregulated in M2- vs. M0-macrophages
and simultaneously upregulated in M2- vs M1-macrophages (i.e. canine M2-macrophage
genes).
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S6 Table. Selected biomarkers predicted to discriminate between canine M1- and M2- mac-
rophages as retrieved and ranked by Prophet.
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